Literature DB >> 24401903

Transmembrane protein with unknown function 16A overexpression promotes glioma formation through the nuclear factor-κB signaling pathway.

Jun Liu1, Yu Liu2, Yingang Ren1, Li Kang1, Lihua Zhang1.   

Abstract

Ion channels have been suggested to be important in the development and progression of tumors, however, chloride channels have rarely been analyzed in tumorigenesis. More recently, transmembrane protein with unknown function 16A (TMEM16A), hypothesized to be a candidate calcium‑activated Cl‑ channel, has been found to be overexpressed in a number of tumor types. Although several studies have implicated the overexpression of TMEM16A in certain tumor types, the exact role of TMEM16A in gliomas and the underlying mechanisms in tumorigenesis, remain poorly understood. In the present study, the role of TMEM16A in gliomas and the potential underlying mechanisms were analyzed. TMEM16A was highly abundant in various grades of gliomas and cultured glioma cells. Knockdown of TMEM16A suppressed cell proliferation, migration and invasion. Furthermore, nuclear factor‑κB (NF‑κB) was activated by overexpression of TMEM16A. In addition, TMEM16A regulated the expression of NF‑κB‑mediated genes, including cyclin D1, cyclin E and c‑myc, involved in cell proliferation, and matrix metalloproteinases (MMPs)‑2 and MMP‑9, which are associated with the migration and invasion of glioma cells. Collectively, results of the present study provide evidence for the involvement of TMEM16A in gliomas and the potential mechanism through which TMEM16A promotes glioma formation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24401903     DOI: 10.3892/mmr.2014.1888

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  32 in total

Review 1.  The multifaceted role of TMEM16A in cancer.

Authors:  David Crottès; Lily Yeh Jan
Journal:  Cell Calcium       Date:  2019-06-14       Impact factor: 6.817

2.  Simvastatin inhibits oral squamous cell carcinoma by targeting TMEM16A Ca2+-activated chloride channel.

Authors:  Hechen Wang; Tianyu Wang; Zeying Zhang; Yu Fan; Lan Zhang; Kuan Gao; Shuya Luo; Qinghuan Xiao; Changfu Sun
Journal:  J Cancer Res Clin Oncol       Date:  2021-03-23       Impact factor: 4.553

Review 3.  Roles, molecular mechanisms, and signaling pathways of TMEMs in neurological diseases.

Authors:  Qinghong Chen; Junlin Fang; Hui Shen; Liping Chen; Mengying Shi; Xianbao Huang; Zhiwei Miao; Yating Gong
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

Review 4.  Role of ANO1 in tumors and tumor immunity.

Authors:  Haini Li; Zongxue Yu; Haiyan Wang; Ning Wang; Xueguo Sun; Shengmei Yang; Xu Hua; Zongtao Liu
Journal:  J Cancer Res Clin Oncol       Date:  2022-04-26       Impact factor: 4.322

Review 5.  Ion Channels and Their Role in the Pathophysiology of Gliomas.

Authors:  Takeshi Takayasu; Kaoru Kurisu; Yoshua Esquenazi; Leomar Y Ballester
Journal:  Mol Cancer Ther       Date:  2020-10       Impact factor: 6.261

6.  ANO1 regulates the maintenance of stemness in glioblastoma stem cells by stabilizing EGFRvIII.

Authors:  Hee-Jin Kim; Jeong-Yub Kim; Chan-Woong Jung; Young-Sun Lee; Joon-Yong An; Eun Ho Kim; Ki-Hong Kim; Sang Pyung Lee; Jae-Yong Park; Myung-Jin Park
Journal:  Oncogene       Date:  2021-01-15       Impact factor: 9.867

7.  Anoctamin1 Induces Hyperproliferation of HaCaT Keratinocytes and Triggers Imiquimod-Induced Psoriasis-Like Skin Injury in Mice.

Authors:  Mi Ran Choi; Hae Dong Kim; Sinyoung Cho; Seong Ho Jeon; Dong Hyun Kim; Jungwon Wee; Young Duk Yang
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

8.  Diethylstilbestrol, a Novel ANO1 Inhibitor, Exerts an Anticancer Effect on Non-Small Cell Lung Cancer via Inhibition of ANO1.

Authors:  Yohan Seo; Sung Baek Jeong; Joo Han Woo; Oh-Bin Kwon; Sion Lee; Hye In Oh; Sungwoo Jo; Seon Ju Park; Wan Namkung; Uk Yeol Moon; Sungwoo Lee
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

9.  Inhibition of TMEM16A suppresses growth and induces apoptosis in hepatocellular carcinoma.

Authors:  Chuantao Zhang; Jianxiang Liu; Zhiyi Han; Xiang Cui; Deti Peng; Yufeng Xing
Journal:  Int J Clin Oncol       Date:  2020-04-02       Impact factor: 3.402

Review 10.  The Ca2+-activated chloride channel ANO1/TMEM16A: An emerging therapeutic target for epithelium-originated diseases?

Authors:  Yani Liu; Zongtao Liu; KeWei Wang
Journal:  Acta Pharm Sin B       Date:  2020-12-09       Impact factor: 11.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.